Guide to Onsite Covid-19 Testing - Vision Research
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Guide to Onsite Covid-19 Testing
6XSSOLHV(TXLSPHQW
Vison R&D is the licensed distributor throughout the UK & Ireland for Mexacare GmbH
with a history of 35 years as a German diagnostic manufacturer.
To ensure validity and efficacy, all rapid testing must be administered by a medical
professional. Through our collaboration with Medel Healthcare, we provide health
6XSSOLHV(TXLSPHQW
professionals on site to manage our clinics.
6XSSOLHV(TXLSPHQW
Nationwide Coverage
Process
Step 1. Patient Books appointment
Using Medel Healthcare App
• Booking Link Generated and passed to Company HR or point of care
• Employees choose appointment time
• Employees fill out pre questionnaire
• Pre Questionnaire is overlooked by our Health Professional
• Required to Download our Health Passport App for results
Step 2. Patient Undergoes Procedure
• Live Schedule gives nurse ability to know the person’s name and
health information (filled in by patient at sign up)
• Performs Procedure, professionally and informatively
• Issues Verbal Result and selects “Detected” “Not Detected”on our
system
• Results issuer adds result to Patients App Profile (This will be
explained further)
Step 3. Patient
Receives 3DWLHQWUHFHLYHV
Result
5HVXOW
• Issuer adds result to patients profile on
health passport Europe application
Onsite Rapid Covid-19 Testing
Services available in Ireland and UK. Pricing on request for UK.
Antigen Test: New Model Sales Pitch
Ability to do multiple locations a day with same testing crew
100 patients:
€15 - Supply Antigen
Nurses €150 p/h
4 Nurses 1h = €600
100 Antigen Supply = €1500
Total €2,100
PCR Test
hen you need to know quickly
Purchasing of tests directly
Services available in Ireland and UK. Pricing on request for UK.
When you need to know quickly
COVID-19 Antigen Rapid Test
What is the MEXACARE COVID-19 Antigen Rapid Test?
Antibody Test €15 each
The MEXACARE Coronavirus Antigen Rapid Test is a rapid chromatographic immunoassay for the qua-
litative detection of SARS-CoV-2 antigens present in the human nasopharynx. One antigen (protein of
COVID-19) is usually detectable in upper respiratory tract samples during the acute phase of infection.
box of 25
Positive results indicate the presence of viral antigens.
Relative Sensitivity 93,48% (95 % CI*: 88,4 %-98,5%)
Relative Specificity 99,62% (95 % CI*: 98,9%->99,9%)
Accuracy 98,01% (95 % CI*: 96,6%-99,47%)
When should I test with the MEXACARE COVID-19 Antigen Rapid Test
Like the RT-PCR test. which is currently the gold standard. an antigen test is able to detect infection with
the novel coronavirus SARS-CoV 2 very early after infection.
€15 pp - Test Alone
In the earliest stages of the disease - during the incubation period (according to the WHO an average of
5-6 days) and in the first 2-3 days after the onset of symptoms. a test with the MEXACARE COVID-19
Antigen Rapid Test is therefore recommended. Since the test detects protein components of the actual
virus (so-called antigens) and not antibodies (the immune reaction of the human body against the virus).
acute infections with SARS-CoV-2 can be detected at this early stage.
The benefits of the MEXACARE COVID-19 Antigen Rapid Test
√ Very high sensitivity (>93 %) and specificity (>99 %)
√ Fast availability of test results (approx. 15 minutes)
√ No expensive laboratory equipment needed
√ No additional reagents required
√ All materials for direct on-site testing included (Point-of-Care)
√ No need to transport samples to the laboratory
Fast and easy test procedure
Package Contents
3 drops of 20 Sealed pouches each con-
extracted specimen positive taining one test cassette and
one desiccant
20 Sterile swabs
20 Specimen collection contai-
ners with extraction buffer
1 Workstation
1 Package insert
negative
Storage
Antigen Test €15 each
2 – 30°C (Room Temperature)
invalid box of 20
Swab 15 min.COVID-19
Antigen Rapid Testing
Vision R & D in collaboration with German manufacturer Mexacare diagnostics is
providing Rapid Covid 19 tests and testing services to UK and Irish companies
facilitating a safer working environment through rapid screening and testing.
Rapid antigen testing is an extremely efficient, economical and reliable process to screen
personnel and provide a high level of security and safety to the working environment.
EU certified effiency Pricing On Professional Medical When
Resultsyou need
within to kn
rating of 98% Request Services 15 minutes
The Antigen Tests are available for purchase in unit volumes of 25
COV
info link: https://visionresearch.io/our-services/professional-testing-services/
What is the MEXACA
Whilst extremely easy and simple to use to ensure validity and efficacyThe
the MEXACARE
tests must beCoro
litative
administered by a professional. A junior doctor or nurse can be provided detection
to make on siteof SA
visits to companies COVID-19) is usually d
Positive results indicat
1. A fully registered NMBI nurse, licenced to work in Ireland with experience in taking
bloods and health screening procedures.
Relative Sensitivity
2. An IMC registered doctor at junior level. Relative Specificity
Accuracy
3. A General Practice doctor on the Specialist Register for GP Services providing a gold
standard service.
When should I test w
Like the RT-PCR test.
the novel coronavirus S
In the earliest stages o
5-6 days) and in the fi
info link: https://visionresearch.io/our-services/medical-sector/ Antigen Rapid Test is t
virus (so-called antigenWhat you need to know quickly
What you need to know
Vision R&D, in collaboration with Mexacare and Medel Healthcare is providing onsite
COVID-19 testing.
According to the HSE and Public Health England, a three-pronged approach is the correct
standard of care to implement when considering this approach to staff safety.
A combination of 1. Antigen testing, 2. PCR testing & 3. Antibody testing is best practice.
This is a complex issue and to simply opt for antigen testing is the wrong approach. It is
documented that if a member of your personnel is antigen tested within 12 weeks of a
positive diagnosis of COVID-19, then antibody testing should be deployed. Unless they are
symptomatic, it must be assumed that they will have residual viral nucleic acid, which
may result in a false positive when using antigen testing.
w
When
quickly
you need to know quickly
COVID-19 Antigen Rapid Test
https://visionresearch.io/our-services/covid-antibody-test/
D-19 Antigen
COVID-19
RapidAntigen
Test Rapid Test
E COVID-19
What is Antigen
the MEXACARE
Rapid Test?COVID-19 Antigen Rapid Test?
What is the MEXACARE COVID-19 Antigen Rapid Test?
virusThe
The
Antigen
MEXACARE
Rapid Test
MEXACARE Coronavirus
is a rapid
Coronavirus Antigen
chromatographic
Antigen Rapid
Rapid Test
Test isimmunoassay
aisrapid
a rapid chromatographic
for the qua-immunoassay
chromatographic immunoassay
S-CoV-2
litative
for theantigens
detectionpresent
qua-litative ofdetection
SARS-CoV-2
in the of
human antigens
nasopharynx.
SARS-CoV-2 present
antigens One
inpresent
the
antigen
human (protein
in thenasopharynx.
human of nasopharynx.
One antigen
ectable
COVID-19)
One in upperis
antigen respiratory
usuallyofdetectable
(protein tract samples
COVID-19) inis upper
during
respiratory
usually the acute
detectable tract
inphase
samples
upper of infection.
during tract
respiratory the acute phase
samples
he presence
Positivethe
during of
results
viral
acuteantigens.
indicate
phasetheofpresence
infection.ofPositive
viral antigens.
results indicate the presence of viral
antigens.
93,48%
Relative(95Sensitivity
% CI*: 88,4 %-98,5%) 93,48% (95 % CI*: 88,4 %-98,5%)
99,62%
Relative(95 % CI*: 98,9%->99,9%)
Specificity 99,62% (95 % CI*: 98,9%->99,9%)
98,01%
Accuracy(95 % CI*: 96,6%-99,47%) 98,01% (95 % CI*: 96,6%-99,47%)
the When
MEXACARE
should COVID-19
I test with Antigen Rapid Test
the MEXACARE COVID-19 Antigen Rapid Test
ich isLike
currently the gold
the RT-PCR standard.
test. which isancurrently
antigenthe
testgold
is able to detect
standard. an infection withis able to detect in
antigen test
RS-CoV 2 verycoronavirus
the novel early after infection.
SARS-CoV 2 very early after infection.
he disease - duringstages
In the earliest the incubation period- (according
of the disease during the to the WHOperiod
incubation an average of to the WHO an
(according
2-3 5-6
daysdays)
afterand
the in
onset of symptoms.
the first a test
2-3 days after with
the the of
onset MEXACARE
symptoms.COVID-19
a test with the MEXACARE
refore recommended.
Antigen Rapid TestSince the testrecommended.
is therefore detects proteinSince
components
the test of the actual
detects protein components o
and virus
not antibodies
(so-called (the immune
antigens) andreaction of the human
not antibodies body against
(the immune reactionthe
of virus).
the human body againsWhat you need to know quickly
What is the MEXACARE COVID-19 Antigen Rapid Test?
The MEXACARE Coronavirus Antigen Rapid Test is a rapid chromatographic immunoassay for the qua-
litative detection of SARS-CoV-2 antigens present in the human nasopharynx. One antigen (protein of
COVID-19 Antigen Rapid Test
COVID-19) is usually detectable in upper respiratory tract samples during the acute phase of infection.
Positive results indicate the presence of viral antigens.
When should
Relative I test with the
Sensitivity MEXACARE
93,48% (95 % CI*:COVID-19 Antigen Rapid Test
88,4 %-98,5%)
Like the RT-PCR
Relative Specificitytest, which
99,62%is currently
(95 % CI*:the gold standard, an antigen test is able to detect
98,9%->99,9%)
infection
Accuracywith the novel coronavirus
98,01% (95 %SARS-CoV 2, very early after infection.
CI*: 96,6%-99,47%)
In the earliest stages of the disease - during the incubation period (according to the WHO
When should I test with the MEXACARE COVID-19 Antigen Rapid Test
an average of 5-6 days) and in the first 2-3 days after the onset of symptoms a test with the
Like the RT-PCR test. which is currently the gold standard. an antigen test is able to detect infection with
MEXACARE COVID-19 Antigen Rapid Test is therefore recommended. Since the test
the novel coronavirus SARS-CoV 2 very early after infection.
detects protein
In the earliest components
stages of the disease of- the actual
during virus (so-called
the incubation antigens)
period (according to theand
WHOnotanantibodies
average of
{the immune reaction of the human body against the virus) acute infections
5-6 days) and in the first 2-3 days after the onset of symptoms. a test with the MEXACARE COVID-19 with
SARS-CoV-2
Antigen Rapid canTest be detected
is therefore at this earlySince
recommended. stage.
the test detects protein components of the actual
virus (so-called antigens) and not antibodies (the immune reaction of the human body against the virus).
acute infections with SARS-CoV-2 can be detected at this early stage.
The
The benefits ofthe
benefits of theMEXACARE
MEXACARE COVID-19
COVID-19 Antigen
Antigen Rapid
Rapid Test Test
√√ Very
Very high sensitivity (>93 %) and specificity (>99 %)
high sensitivity (>93 %) and specificity (>99 %)
√ Fast availability
√ Fast availability of
of test
testresults
results(approx.
(approx.15 15
minutes)
minutes)
√ No expensive laboratory equipment needed
√ No expensive laboratory equipment needed
√√ NoNoadditional
additional reagents required
reagents required
√√ AllAllmaterials
materials forfordirect
directon-site
on-site testing
testing included
included (Point-of-Care)
(Point-of-Care)
√√ NoNoneed
needtoto transport samplestoto
transport samples the
the laboratory
laboratory
FastFast
andand
easy
easytest procedure
test procedure
the qua- Package Contents
protein of
3 drops of 20 Sealed pouches each con-
extracted specimen positive taining one test cassette and
infection. one desiccant
20 Sterile swabs
20 Specimen collection contai-
ners with extraction buffer
1 Workstation
1 Package insert
negative
Storage
2 – 30°C (Room Temperature)
invalid
ction with Swab 15 min.
verage of
COVID-19
he actual
he virus).Whatyou need to know quickly
COVID-19 IgG/IgM
COVID-19 Rapid
IgG/IgM Rapid Test Test Antibody
What is the MEXACARE COVID-19 lgG/lgM Rapid Test?
The
What isMEXACARE
the MEXACARE COVID-19
COVID-19 lgG/lgM
IgG/IgM Rapid Antibody
Test? Test is a rapid, qualitative
immunochromatographic as-say for the differential detection of lgM & lgG antibodies
The MEXACARE
against SARS CoV-2COVID-19virusIgG/IgM Antibody
in human serum,Test plasma
is a rapid,orqualitative
whole bloodimmunochromatographic
samples. The testas- is
say for thefor
intended differential detection of IgM
the determination of a& current
IgG antibodies
or past against SARSwith
infection CoV-2
thevirus in human serum,
SARS-CoV-2 virus
plasma or whole blood samples. The test is intended for the determination
and for monitoring the disease status after SARS-CoV-2 virus infection. The MEXACAREof a current or past infection
with the SARS-CoV-2 virus and for monitoring the disease status after SARS-CoV-2 virus infection.
COVID-19 lgG/lgM Rapid Test has a sensitivity of 94.55% and a specificity of 97.26%.
The MEXACARE COVID-19 IgG/IgM Rapid Test has a sensitivity of 94.55% and a specificity of 97.26%.
MEXACARE GmbH is an ISO 13485 certified manufacturer for rapid medical tests.
MEXACARE GmbH is an ISO 13485 certified manufacturer for rapid medical tests.
When shouldI Itest
When should testwith
withthe the MEXACARE
MEXACARE COVID-19
COVID-19 lgG/lgM
IgG/IgM Rapid
Rapid Test?
Test?
The MEXACARE COVID-19 lgG/lgM Rapid Test is intended to complement the RT-PCR
tests, which areCOVID-19
The MEXACARE currentlyIgG/IgM
performedRapid inTest
large numberstoby
is intended doctors, laboratories
complement and public
the RT-PCR tests, which
health authorities throug-hout the world in the fight against the novel Corona-Virus
are currently performed in large numbers by doctors, laboratories and public health authorities throug-
SARS-CoV-2.
hout the world in the fight against the novel Corona-Virus SARS-CoV-2.
During
During thetheearliest
earliest stages
stages of theof the disease
disease - in the period
- in the incubation incubation period
(according (according
to WHO to WHO
around 5-6 days
around 5-6and
on average) days onontheaverage) andafter
first 2-3 days on the first 2-3
the onset days after
of symptoms theRT-PCR
- only onset of cansymptoms - only
give you satisfac-
tory test results as the body has not produced antibodies in detectable quantities.
RT-PCR can give you satisfac-tory test results as the body has not produced antibodies in
3-5 days after
detectable the onset of the disease‘s symptoms (cough, light fever, sore throat) IgM antibodies can
quantities.
already
3-5 days beafter
detected
the inonset
the blood.
of theAt disease’s
this point, testing
symptoms with the MEXACARE
(cough, light COVID-19
fever, soreIgG/IgM
throat)Rapid
lgM
test is recommended as positive results can now be obtained. IgG antibodies are produced later by the
antibodies can already be detected in the blood. At this point, testing with the MEXACARE
immune system and are detectable in the body for a long time after recovery. In this way, undetected
COVID-19 lgG/lgM Rapid test is recommended as positive results can now be obtained.
infections (e.g. infections that proceed without symptoms) or the serological protection of the test sub-
lgG antibodies
ject can are produced later by the immune system and are detectable in the body
be determined.
for a long time after recovery. In this way, undetected infections (e.g. infections that
proceed without symptoms) or the serological protection of the test sub-ject can be
determined.
Stages of COVID-19 disease according to current state of knowledge:
Infectious - day -2 to +14 :
Patient excretes infectious
amounts of Sars-Cov-2 virus
- on average 2-3 more people
become ill (1)
Healthy without symptoms: until
day 0 and from day +10 to +14
at the earliest: Patient has no
fever for at least 48 hours and
no symptoms of infection for at
least 24 hours.
In addition, the RKI requires two
negative tests for the virus with
a 24-hour difference. (2)
Immune: specific antibodies IgG
against the corona virus signal
immunity. For how long? Ana-
logy to the other corona viruses
some years (3)All advantages of the
COVID-19 Antigen Rapid Test
√ Test cassette for qualitative detection
√ Fast, simple, inexpensive - no laboratory equipment required
√ Safe Point of Care test with results within 15-20 minutes
√ High Accuracy (>98) enables reliable detection of infected patients
√ High specificity (>99%) prevents false positive results
All advantages
√ Detection of the
of viruses by antigens
COVID-19 Antigen Rapid Test:
√ Complements MEXACARE COVID-19 IgG/IgM Antibody Rapid Test and RT-PCR as a
RESEAR CH + DE VELOPMENT
√ Test cassette for qualitative detection
√
powerful tool forcomprehensive diagnosis
Fast, simple, inexpensive - no laboratory equipment required
√ √ Checking the risk of infection by patients
Safe Point of Care test with results within 15-20 minutes
√ √ Offers the possibility of effective screening of large parts of the population
High sensitivity (>93%) enables reliable detection of infected persons
√ High specificity (>98%) prevents false positive results
√ Detection of viruses by antigens
√ Complements MEXACARE COVID-19 IgG/IgM Antibody Rapid Test and RT-PCR as a powerful tool for
comprehensive diagnosis Accurate Rapid Tests from Your
√ Checking the risk of infection by patients
√ Offers the possibility of effective screening of large parts of the population COVID-19 Antigen
Catalogue No. Description No. of tests
3011030 MEXACARE COVID-19 Antigen Rapid Test 20
3011016 MEXACARE Influenza A+B Antigen Rapid Test 20
3011033 MEXACARE COVID-19 & Influenza A+B Ag Combo Rapid Test 20
All tests are CE certified
RESEARCH + DEVELOPMENT
8QLW0%XVLQHVV3DUN
MEXACARE GmbH
%DOO\PRXQW$YHQXH%DOO\PRXQW
-
Hans-Bunte-Str. 6
69123 Heidelberg
Germany
phone +49 (0) 62 21- 90682-41
fax,QIR#YLVLRQUHVHDUFKLR
+49 (0) 62 21- 90682-47
www.mexacare.comYou can also read
